Work

Clinical and immune characteristics of rapid dropout and long-term survival in a phase II safety and efficacy study of combination CRS-207/GVAX immunotherapy in pancreatic cancer.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.4_suppl.459

Authors: Dung T. Le, Chan C. Whiting, Eric R. Lutz, Nitya Nair, Amanda Engstrom, Ed Lemmens, Margit Cecile Tagliaferri, Aimee L. Murphy, Dirk G. Brockstedt, Elizabeth M. Jaffee

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Aduro BioTech (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2482969688

Cites:

Cited by: 4

Related to: 10